Gaush Meditech Ltd (2407.HK)

HKD 10.1

(-1.94%)

EBITDA Summary of Gaush Meditech Ltd

  • Gaush Meditech Ltd's latest annual EBITDA in 2023 was 374.3 Million CNY , up 162.97% from previous year.
  • Gaush Meditech Ltd's latest quarterly EBITDA in 2024 Q2 was 45.35 Million CNY , down 0.0% from previous quarter.
  • Gaush Meditech Ltd reported an annual EBITDA of 140.75 Million CNY in 2022, down -63.07% from previous year.
  • Gaush Meditech Ltd reported an annual EBITDA of 381.13 Million CNY in 2021, up 67.96% from previous year.
  • Gaush Meditech Ltd reported a quarterly EBITDA of 45.35 Million CNY for 2024 Q2, down 0.0% from previous quarter.
  • Gaush Meditech Ltd reported a quarterly EBITDA of 85.23 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of Gaush Meditech Ltd (2023 - 2019)

Historical Annual EBITDA of Gaush Meditech Ltd (2023 - 2019)

Year EBITDA EBITDA Growth
2023 374.3 Million CNY 162.97%
2022 140.75 Million CNY -63.07%
2021 381.13 Million CNY 67.96%
2020 226.92 Million CNY 24.46%
2019 182.32 Million CNY 0.0%

Peer EBITDA Comparison of Gaush Meditech Ltd

Name EBITDA EBITDA Difference